BMRN logo

BioMarin Pharmaceutical (BMRN) Selling, general & administrative expenses

annual SGA:

$1.01B+$71.72M(+7.65%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual SGA is $1.01 billion, with the most recent change of +$71.72 million (+7.65%) on December 31, 2024.
  • During the last 3 years, BMRN annual SGA has risen by +$249.63 million (+32.87%).
  • BMRN annual SGA is now at all-time high.

Performance

BMRN SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly SGA:

$206.10M-$60.50M(-22.69%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly SGA is $206.10 million, with the most recent change of -$60.50 million (-22.69%) on March 31, 2025.
  • Over the past year, BMRN quarterly SGA has dropped by -$19.80 million (-8.76%).
  • BMRN quarterly SGA is now -22.69% below its all-time high of $266.60 million, reached on December 31, 2024.

Performance

BMRN quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM SGA:

-$949.06M+$523.88M(+35.57%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN TTM SGA is -$949.06 million, with the most recent change of +$523.88 million (+35.57%) on March 31, 2025.
  • Over the past year, BMRN TTM SGA has dropped by -$1.81 billion (-209.83%).
  • BMRN TTM SGA is now -4742.14% below its all-time high of -$19.60 million.

Performance

BMRN TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

BMRN Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.7%-8.8%-209.8%
3 y3 years+32.9%+5.9%-221.7%
5 y5 years+48.2%+10.0%-231.7%

BMRN Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+32.9%-22.7%+19.4%at high+71.9%
5 y5-yearat high+48.2%-22.7%+19.4%at high+86.0%
alltimeall timeat high>+9999.0%-22.7%>+9999.0%-4742.1%+86.4%

BMRN Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$206.10M(-22.7%)
$989.23M(-2.0%)
Dec 2024
$1.01B(+7.7%)
$266.60M(+5.2%)
$1.01B(+0.7%)
Sep 2024
-
$253.50M(-3.6%)
$1.00B(+8.8%)
Jun 2024
-
$263.03M(+16.4%)
$921.03M(+6.6%)
Mar 2024
-
$225.90M(-12.9%)
$864.10M(+1.8%)
Dec 2023
$937.30M(+9.8%)
$259.50M(+50.3%)
$849.23M(+5.5%)
Sep 2023
-
$172.60M(-16.3%)
$804.63M(-5.2%)
Jun 2023
-
$206.10M(-2.3%)
$848.83M(+1.1%)
Mar 2023
-
$211.02M(-1.8%)
$839.56M(+2.0%)
Dec 2022
$854.00M(+12.5%)
$214.90M(-0.9%)
$823.15M(-0.3%)
Sep 2022
-
$216.80M(+10.1%)
$825.85M(+4.2%)
Jun 2022
-
$196.84M(+1.1%)
$792.35M(+1.6%)
Mar 2022
-
$194.62M(-10.6%)
$779.72M(+2.7%)
Dec 2021
$759.40M(+2.9%)
$217.60M(+18.7%)
$759.40M(+3.0%)
Sep 2021
-
$183.30M(-0.5%)
$737.30M(+0.5%)
Jun 2021
-
$184.20M(+5.7%)
$733.50M(+1.2%)
Mar 2021
-
$174.30M(-10.8%)
$724.70M(-1.8%)
Dec 2020
$737.70M(+8.3%)
$195.50M(+8.9%)
$737.70M(+1.0%)
Sep 2020
-
$179.50M(+2.3%)
$730.08M(+1.3%)
Jun 2020
-
$175.40M(-6.4%)
$720.69M(+2.1%)
Mar 2020
-
$187.30M(-0.3%)
$705.99M(+3.7%)
Dec 2019
$680.90M(+12.7%)
$187.88M(+10.4%)
$680.85M(+3.6%)
Sep 2019
-
$170.11M(+5.9%)
$657.19M(+3.4%)
Jun 2019
-
$160.70M(-0.9%)
$635.64M(+1.2%)
Mar 2019
-
$162.16M(-1.3%)
$628.22M(+3.9%)
Dec 2018
$604.40M(+9.0%)
$164.22M(+10.5%)
$604.40M(+0.7%)
Sep 2018
-
$148.57M(-3.1%)
$600.46M(+3.1%)
Jun 2018
-
$153.28M(+10.8%)
$582.43M(+1.7%)
Mar 2018
-
$138.34M(-13.7%)
$572.65M(+3.3%)
Dec 2017
$554.34M(+16.3%)
$160.28M(+22.8%)
$554.34M(+3.2%)
Sep 2017
-
$130.53M(-9.0%)
$537.01M(+2.2%)
Jun 2017
-
$143.50M(+19.6%)
$525.24M(+6.9%)
Mar 2017
-
$120.02M(-16.0%)
$491.31M(+3.1%)
Dec 2016
$476.59M(+18.5%)
$142.96M(+20.4%)
$476.59M(+6.5%)
Sep 2016
-
$118.76M(+8.4%)
$447.54M(+5.8%)
Jun 2016
-
$109.58M(+4.1%)
$422.83M(+1.9%)
Mar 2016
-
$105.30M(-7.6%)
$414.76M(+3.1%)
Dec 2015
$402.27M(+33.1%)
$113.91M(+21.1%)
$402.27M(+3.6%)
Sep 2015
-
$94.04M(-7.4%)
$388.13M(+5.3%)
Jun 2015
-
$101.51M(+9.4%)
$368.69M(+10.0%)
Mar 2015
-
$92.81M(-7.0%)
$335.27M(+10.8%)
Dec 2014
$302.16M(+28.4%)
$99.77M(+33.7%)
$302.53M(+10.2%)
Sep 2014
-
$74.60M(+9.6%)
$274.57M(+4.9%)
Jun 2014
-
$68.09M(+13.4%)
$261.81M(+7.1%)
Mar 2014
-
$60.07M(-16.3%)
$244.38M(+3.8%)
Dec 2013
$235.36M(+18.8%)
$71.81M(+16.1%)
$235.36M(+7.7%)
Sep 2013
-
$61.84M(+22.1%)
$218.60M(+7.6%)
Jun 2013
-
$50.66M(-0.8%)
$203.09M(-0.4%)
Mar 2013
-
$51.05M(-7.3%)
$203.97M(+2.9%)
Dec 2012
$198.17M(+13.0%)
$55.05M(+18.8%)
$198.17M(+3.4%)
Sep 2012
-
$46.34M(-10.1%)
$191.58M(+0.8%)
Jun 2012
-
$51.54M(+13.9%)
$190.12M(+5.9%)
Mar 2012
-
$45.25M(-6.6%)
$179.60M(+2.4%)
DateAnnualQuarterlyTTM
Dec 2011
$175.42M(+15.6%)
$48.45M(+8.0%)
$175.39M(+3.8%)
Sep 2011
-
$44.88M(+9.4%)
$169.03M(+4.0%)
Jun 2011
-
$41.02M(-0.1%)
$162.50M(+2.4%)
Mar 2011
-
$41.04M(-2.5%)
$158.76M(+4.6%)
Dec 2010
$151.72M(+22.1%)
$42.10M(+9.8%)
$151.72M(+3.8%)
Sep 2010
-
$38.35M(+2.9%)
$146.15M(+7.1%)
Jun 2010
-
$37.28M(+9.6%)
$136.47M(+5.2%)
Mar 2010
-
$34.00M(-6.9%)
$129.72M(+4.4%)
Dec 2009
$124.29M(+16.6%)
$36.53M(+27.4%)
$124.29M(+6.7%)
Sep 2009
-
$28.67M(-6.1%)
$116.49M(-0.3%)
Jun 2009
-
$30.53M(+6.9%)
$116.79M(+4.8%)
Mar 2009
-
$28.57M(-0.6%)
$111.47M(+4.6%)
Dec 2008
$106.57M(+37.4%)
$28.73M(-0.8%)
$106.57M(+4.2%)
Sep 2008
-
$28.96M(+14.9%)
$102.30M(+10.2%)
Jun 2008
-
$25.20M(+6.5%)
$92.86M(+8.9%)
Mar 2008
-
$23.67M(-3.2%)
$85.30M(+9.5%)
Dec 2007
$77.54M(+58.1%)
$24.46M(+25.3%)
$77.89M(+15.6%)
Sep 2007
-
$19.52M(+10.6%)
$67.40M(+12.0%)
Jun 2007
-
$17.65M(+8.6%)
$60.17M(+10.6%)
Mar 2007
-
$16.26M(+16.4%)
$54.39M(+10.9%)
Dec 2006
$49.03M(+18.0%)
$13.97M(+13.7%)
$49.03M(+6.3%)
Sep 2006
-
$12.29M(+3.5%)
$46.13M(+5.7%)
Jun 2006
-
$11.87M(+8.9%)
$43.64M(+4.2%)
Mar 2006
-
$10.90M(-1.6%)
$41.89M(+0.8%)
Dec 2005
$41.56M(+10.5%)
$11.08M(+13.1%)
$41.56M(-5.1%)
Sep 2005
-
$9.80M(-3.2%)
$43.78M(-6.3%)
Jun 2005
-
$10.12M(-4.3%)
$46.75M(+5.8%)
Mar 2005
-
$10.57M(-20.6%)
$44.17M(+17.8%)
Dec 2004
$37.61M(+161.2%)
$13.30M(+4.2%)
$37.48M(+26.4%)
Sep 2004
-
$12.76M(+69.3%)
$29.66M(+59.8%)
Jun 2004
-
$7.54M(+94.3%)
$18.56M(+19.9%)
Mar 2004
-
$3.88M(-29.1%)
$15.48M(+7.5%)
Dec 2003
$14.40M(-14.7%)
$5.47M(+229.4%)
$14.40M(-3.1%)
Sep 2003
-
$1.66M(-62.7%)
$14.86M(-13.3%)
Jun 2003
-
$4.46M(+59.3%)
$17.14M(+8.9%)
Mar 2003
-
$2.80M(-52.9%)
$15.74M(-6.7%)
Dec 2002
$16.87M(+164.0%)
$5.94M(+50.8%)
$16.87M(+71.9%)
Sep 2002
-
$3.94M(+28.7%)
$9.81M(+10.7%)
Jun 2002
-
$3.06M(-22.0%)
$8.87M(+20.8%)
Mar 2002
-
$3.93M(-452.4%)
$7.34M(+50.2%)
Dec 2001
$6.39M(-1.8%)
-$1.11M(-137.2%)
$4.89M(-18.4%)
Sep 2001
-
$2.99M(+94.9%)
$5.99M(+12.4%)
Jun 2001
-
$1.54M(+4.2%)
$5.33M(-10.9%)
Mar 2001
-
$1.47M(<-9900.0%)
$5.99M(-8.0%)
Dec 2000
$6.51M(+36.8%)
-$10.00K(-100.4%)
$6.51M(+0.5%)
Sep 2000
-
$2.33M(+6.4%)
$6.47M(+5.4%)
Jun 2000
-
$2.19M(+9.7%)
$6.14M(+21.6%)
Mar 2000
-
$2.00M(-4741.9%)
$5.05M(+6.4%)
Dec 1999
$4.76M(+35.9%)
-$43.00K(-102.2%)
$4.75M(-0.9%)
Sep 1999
-
$2.00M(+81.8%)
$4.79M(+71.6%)
Jun 1999
-
$1.10M(-35.0%)
$2.79M(+65.0%)
Mar 1999
-
$1.69M
$1.69M
Dec 1998
$3.50M
-
-

FAQ

  • What is BioMarin Pharmaceutical annual SGA?
  • What is the all time high annual SGA for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual SGA year-on-year change?
  • What is BioMarin Pharmaceutical quarterly SGA?
  • What is the all time high quarterly SGA for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly SGA year-on-year change?
  • What is BioMarin Pharmaceutical TTM SGA?
  • What is the all time high TTM SGA for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM SGA year-on-year change?

What is BioMarin Pharmaceutical annual SGA?

The current annual SGA of BMRN is $1.01B

What is the all time high annual SGA for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual SGA is $1.01B

What is BioMarin Pharmaceutical annual SGA year-on-year change?

Over the past year, BMRN annual SGA has changed by +$71.72M (+7.65%)

What is BioMarin Pharmaceutical quarterly SGA?

The current quarterly SGA of BMRN is $206.10M

What is the all time high quarterly SGA for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly SGA is $266.60M

What is BioMarin Pharmaceutical quarterly SGA year-on-year change?

Over the past year, BMRN quarterly SGA has changed by -$19.80M (-8.76%)

What is BioMarin Pharmaceutical TTM SGA?

The current TTM SGA of BMRN is -$949.06M

What is the all time high TTM SGA for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM SGA is -$19.60M

What is BioMarin Pharmaceutical TTM SGA year-on-year change?

Over the past year, BMRN TTM SGA has changed by -$1.81B (-209.83%)
On this page